Mcdaniel Terry & Co. Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

Mcdaniel Terry & Co. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 69,963 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Intuitive Surgical accounts for 3.1% of Mcdaniel Terry & Co.’s investment portfolio, making the stock its 14th biggest holding. Mcdaniel Terry & Co.’s holdings in Intuitive Surgical were worth $38,019,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the stock. Nuveen LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at $1,715,899,000. Goldman Sachs Group Inc. boosted its holdings in shares of Intuitive Surgical by 26.1% in the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after acquiring an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Wellington Management Group LLP raised its holdings in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $546.51 on Friday. The firm’s 50-day moving average is $458.09 and its two-hundred day moving average is $497.02. The company has a market capitalization of $195.91 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 5.50 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.84 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ISRG. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday. Daiwa Capital Markets upped their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday. Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a report on Tuesday, October 7th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the transaction, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,724 shares of company stock worth $19,500,332 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.